Gross margin, operating expenses, net loss, and net loss per share are reported on a GAAP and non-GAAP basis. The non-GAAP measures are described below and reconciled to the corresponding GAAP ...
MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced preliminary unaudited revenue for the ...
MENLO PARK, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2024. Third quarter results: Revenue of $40.0 million ...
PacBio reported Q1 2025 revenue of $37.2 million, a decrease from $38.8 million in Q1 2024, amid restructuring efforts. PacBio reported its financial results for the first quarter of 2025, revealing a ...
Gross margin, operating expenses, net income (loss), and net income (loss) per share are reported on a GAAP and non-GAAP basis. The non-GAAP measures are described below and reconciled to the ...
MENLO PARK, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- PacBio (PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2025 financial results on Thursday, ...
MENLO PARK, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2025 financial results on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback